$161 Million is the total value of DAFNA Capital Management LLC's 73 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 37.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LOXO | Sell | LOXO ONCOLOGY INC | $24,147,000 | -0.8% | 262,121 | -13.7% | 14.99% | -13.7% |
| ATRC | ATRICURE INC | $8,593,000 | -7.8% | 384,145 | 0.0% | 5.34% | -19.7% | |
| BGNE | Sell | BEIGENE LTDsponsored adr | $7,433,000 | +126.1% | 71,849 | -1.6% | 4.62% | +96.7% |
| IMMU | Sell | IMMUNOMEDICS INC | $6,437,000 | +14.3% | 460,451 | -27.8% | 4.00% | -0.5% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $6,253,000 | +90.2% | 1,193,228 | +101.9% | 3.88% | +65.5% |
| NXTM | NXSTAGE MEDICAL INC | $5,965,000 | +10.1% | 216,119 | 0.0% | 3.70% | -4.2% | |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $5,675,000 | +1.1% | 116,770 | +9.4% | 3.52% | -12.0% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $5,295,000 | +27.4% | 76,000 | -7.3% | 3.29% | +10.9% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $4,239,000 | +67.5% | 346,013 | +56.6% | 2.63% | +45.7% |
| New | RADIUS HEALTH INCnote 3.000% 9/0 | $4,000,000 | – | 4,000,000 | +100.0% | 2.48% | – | |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $3,506,000 | +3087.3% | 435,000 | +2181.4% | 2.18% | +2691.0% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $3,340,000 | +33.2% | 54,508 | 0.0% | 2.07% | +15.9% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS | $3,225,000 | +163.7% | 718,272 | +169.5% | 2.00% | +129.3% |
| GLPG | Sell | GALAPAGOS NVspon adr | $3,216,000 | +8.9% | 31,609 | -18.1% | 2.00% | -5.3% |
| PODD | Sell | INSULET CORP | $3,166,000 | -2.8% | 57,484 | -9.5% | 1.97% | -15.4% |
| IBB | ISHARES TR NASDQ BIOTECHetf | $2,902,000 | +7.6% | 8,700 | 0.0% | 1.80% | -6.4% | |
| MGNX | Buy | MACROGENICS INC | $2,850,000 | +36.6% | 154,200 | +29.4% | 1.77% | +18.9% |
| DXCM | New | DEXCOM INC | $2,813,000 | – | 57,500 | +100.0% | 1.75% | – |
| INSULET CORPnote 2.000% 6/1 | $2,814,000 | +2.5% | 2,250,000 | 0.0% | 1.75% | -10.8% | ||
| AKBA | AKEBIA THERAPEUTICS INC | $2,670,000 | +36.9% | 135,738 | 0.0% | 1.66% | +19.1% | |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $2,618,000 | +183.9% | 72,226 | +117.5% | 1.63% | +147.1% |
| VYGR | Sell | VOYAGER THERAPEUTICS INC | $2,414,000 | +31.6% | 117,259 | -42.7% | 1.50% | +14.5% |
| PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $2,125,000 | +9.8% | 2,500,000 | 0.0% | 1.32% | -4.5% | ||
| RDUS | RADIUS HEALTH INC | $2,055,000 | -14.8% | 53,309 | 0.0% | 1.28% | -25.8% | |
| DERM | DERMIRA INC | $2,039,000 | -7.3% | 75,500 | 0.0% | 1.27% | -19.4% | |
| ZGNX | Sell | ZOGENIX INC | $1,840,000 | +127.4% | 52,500 | -5.9% | 1.14% | +97.9% |
| ARDX | Sell | ARDELYX INC | $1,822,000 | -4.3% | 325,409 | -12.9% | 1.13% | -16.8% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $1,723,000 | +28.0% | 349,592 | 0.0% | 1.07% | +11.5% | |
| CDTX | CIDARA THERAPEUTICS INC | $1,689,000 | +8.1% | 208,458 | 0.0% | 1.05% | -5.9% | |
| QURE | Sell | UNIQURE N V | $1,683,000 | +33.4% | 175,307 | -14.0% | 1.04% | +16.0% |
| AGTC | APPLIED GENETIC TECHNOL CORP | $1,663,000 | -22.5% | 421,000 | 0.0% | 1.03% | -32.6% | |
| BEAT | Sell | BIOTELEMETRY INC | $1,650,000 | -34.2% | 50,000 | -33.3% | 1.02% | -42.7% |
| DERMIRA INCnote 3.000% 5/1 | $1,624,000 | -2.5% | 1,500,000 | 0.0% | 1.01% | -15.2% | ||
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $1,613,000 | -29.7% | 831,332 | -2.2% | 1.00% | -38.8% |
| KURA | New | KURA ONCOLOGY INC | $1,583,000 | – | 105,859 | +100.0% | 0.98% | – |
| NEURODERM LTD | $1,476,000 | +30.2% | 37,938 | 0.0% | 0.92% | +13.2% | ||
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $1,436,000 | -13.0% | 258,667 | -27.3% | 0.89% | -24.2% |
| NERV | Sell | MINERVA NEUROSCIENCES INC | $1,300,000 | -46.8% | 171,094 | -38.1% | 0.81% | -53.8% |
| CARA | New | CARA THERAPEUTICS INC | $1,284,000 | – | 93,800 | +100.0% | 0.80% | – |
| SCYX | SCYNEXIS INC | $1,222,000 | +34.7% | 506,900 | 0.0% | 0.76% | +17.3% | |
| JNJ | JOHNSON AND JOHNSON | $1,222,000 | -1.8% | 9,400 | 0.0% | 0.76% | -14.5% | |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $1,129,000 | – | 79,542 | +100.0% | 0.70% | – |
| STXS | STEREOTAXIS INC | $1,126,000 | +41.5% | 1,372,862 | 0.0% | 0.70% | +23.1% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $1,126,000 | -7.0% | 443,478 | 0.0% | 0.70% | -19.1% | |
| XENE | XENON PHARMACEUTICALS INC | $1,114,000 | -6.4% | 377,695 | 0.0% | 0.69% | -18.5% | |
| ADXS | ADVAXIS INC | $1,032,000 | -35.6% | 247,000 | 0.0% | 0.64% | -44.0% | |
| CMTA | New | CLEMENTIA PHARMACEUTICALS IN | $1,013,000 | – | 60,000 | +100.0% | 0.63% | – |
| EXAC | Buy | EXACTECH INC | $907,000 | +31.6% | 27,532 | +19.0% | 0.56% | +14.4% |
| ARGX | ARGENX SEsponsored adr | $904,000 | +6.6% | 40,000 | 0.0% | 0.56% | -7.3% | |
| CGNT | Sell | COGENTIX MEDICAL INC | $828,000 | +34.6% | 323,482 | -8.5% | 0.51% | +17.1% |
| OBSV | Buy | OBSEVA SA | $700,000 | +227.1% | 86,000 | +244.0% | 0.44% | +184.3% |
| IRONWOOD PHARMACEUTICALS INCdbcv 2.250% 6/1 | $682,000 | -11.1% | 573,000 | 0.0% | 0.42% | -22.7% | ||
| BLUE | Sell | BLUEBIRD BIO INC | $618,000 | -26.4% | 4,500 | -43.8% | 0.38% | -35.9% |
| LMNX | New | LUMINEX CORP DEL | $508,000 | – | 25,000 | +100.0% | 0.32% | – |
| CASC | CASCADIAN THERAPEUTICS INC | $480,000 | +10.1% | 117,310 | 0.0% | 0.30% | -4.2% | |
| ARQL | Sell | ARQULE INC | $475,000 | -51.2% | 427,478 | -45.5% | 0.30% | -57.5% |
| INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 | $461,000 | +24.9% | 600,000 | 0.0% | 0.29% | +8.7% | ||
| MASI | Buy | MASIMO CORPORATION | $433,000 | +11.6% | 5,000 | +17.6% | 0.27% | -2.9% |
| KDMN | New | KADMON HOLDINGS INC | $419,000 | – | 125,000 | +100.0% | 0.26% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $380,000 | – | 20,000 | +100.0% | 0.24% | – |
| NTUS | NATUS MEDICAL INC DEL | $296,000 | +0.3% | 7,900 | 0.0% | 0.18% | -12.8% | |
| NEOS | Sell | NEOS THERAPEUTICS INC | $252,000 | -83.6% | 27,500 | -86.9% | 0.16% | -85.7% |
| BLCM | BELLICUM PHARMACEUTICALS INC | $231,000 | -1.3% | 20,000 | 0.0% | 0.14% | -14.4% | |
| DEXCOM INCdbcv 0.750% 5/1 | $223,000 | -12.2% | 250,000 | 0.0% | 0.14% | -23.8% | ||
| EDGE | EDGE THERAPEUTICS INC | $208,000 | +4.5% | 19,400 | 0.0% | 0.13% | -9.2% | |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $192,000 | – | 333,000 | +100.0% | 0.12% | – |
| OPHT | New | OPHTHOTECH CORP | $141,000 | – | 50,000 | +100.0% | 0.09% | – |
| ADMP | ADAMIS PHARMACEUTICALS CORP | $127,000 | 0.0% | 24,401 | 0.0% | 0.08% | -13.2% | |
| New | INTEC PHARMA LTD JERUSALEM | $126,000 | – | 14,100 | +100.0% | 0.08% | – | |
| SBPH | Buy | SPRING BANK PHARMACEUTICALS | $110,000 | -49.3% | 6,507 | +306.7% | 0.07% | -56.1% |
| CTMX | New | CYTOMX THERAPEUTICS INC | $107,000 | – | 5,900 | +100.0% | 0.07% | – |
| SRRA | Sell | SIERRA ONCOLOGY INC | $68,000 | -78.1% | 44,000 | -83.4% | 0.04% | -81.0% |
| GALE | GALENA BIOPHARMA INC | $16,000 | -40.7% | 46,145 | 0.0% | 0.01% | -47.4% | |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -20,000 | -100.0% | -0.06% | – | |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -5,500 | -100.0% | -0.09% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -20,000 | -100.0% | -0.12% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -92,500 | -100.0% | -0.14% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -15,550 | -100.0% | -0.19% | – |
| EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -35,977 | -100.0% | -0.20% | – |
| CNAT | Exit | CONATUS PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.21% | – |
| GEMP | Exit | GEMPHIRE THERAPEUTICS INC | $0 | – | -30,797 | -100.0% | -0.28% | – |
| ITEK | Exit | INOTEK PHARMACEUTICALS CORP | $0 | – | -237,135 | -100.0% | -0.32% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -724,286 | -100.0% | -0.41% | – |
| BLRX | Exit | BIOLINERX LTDsponsored adr | $0 | – | -980,352 | -100.0% | -0.59% | – |
| ELOS | Exit | SYNERON MEDICAL LTD | $0 | – | -85,947 | -100.0% | -0.67% | – |
| CLLS | Exit | CELLECTIS S Asponsored adr | $0 | – | -76,404 | -100.0% | -1.41% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -225,000 | -100.0% | -1.41% | – |
| SPNC | Exit | SPECTRANETICS CORP | $0 | – | -55,896 | -100.0% | -1.53% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.